Critical role of TCF-1 on the epigenetic identity of memory T cells
TCF-1 对记忆 T 细胞表观遗传特性的关键作用
基本信息
- 批准号:10549303
- 负责人:
- 金额:$ 45.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-15 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdaptive Immune SystemAreaBindingBinding SitesBiological AssayCD8-Positive T-LymphocytesCell physiologyCellsChromatinCollaborationsCombined Modality TherapyConsensusDataDevelopmentDiseaseEffector CellEpigenetic ProcessEventFOXO1A geneFlow CytometryFoundationsGene Expression ProfileGenerationsGenesGenomeGenomic SegmentGoalsIn VitroInfectionMachine LearningMapsMediatingMemoryMolecularMonitorOrgan TransplantationOutcomePeripheralProteinsRegulatory ElementResearchResolutionRoleSiteT cell differentiationT cell responseT memory cellT-Cell ActivationT-Cell DevelopmentT-LymphocyteTCF Transcription FactorTechniquesTertiary Protein StructureTestingThymus GlandTranslatingcell typechronic infectionepigenomeepigenomicsimmunoregulationin vivomembermutantnovelnovel therapeutic interventionpathogenpermissivenesssynergismtooltranscription factortranscriptomics
项目摘要
The goal of this proposal is to study the role of transcription factor TCF-1 in determining the epigenetic identity
of memory CD8+ T cells. Our adaptive immune system has evolved a unique capacity to remember a pathogen
through the generation of memory T cells, which protect the host in the event of reinfection. A better
understanding of memory T cell differentiation is crucial for developing strategies to limit T cell responses in
organ transplantation or enhance T cell responses during chronic infections. Although it is known that the
transcription factor TCF-1 is required for memory CD8+ T cell function, the mechanisms through which this
protein controls memory T cell fate remain unclear. Recently, we discovered that a mechanism through which
TCF-1 controls the development of T cells relates to its unprecedented ability to create the chromatin
accessibility landscape of naïve T cells. We found that TCF-1 is selectively enriched at genomic regions that
become accessible at the earliest stages of development and is required for the accessibility of these
regulatory elements. At the single-cell level, TCF-1 can dictate a coordinate opening of chromatin in T cells.
Moreover, ectopic TCF-1 can directly erase repressive chromatin marks in non-T cells, generating de novo
open chromatin and inducing the expression of T cell genes. While our recent data determined the novel role
of TCF-1 on the epigenome during T cell development, our findings also raised another critical question: what
is the role of TCF-1 on the epigenetic identity of memory T cells? We hypothesize that TCF-1 in cooperation
with transcription factor partners defines the epigenetic landscape of memory T cells. Our new preliminary data
further indicate that TCF-1 expression post T cell activation in vitro can lead to gains in chromatin accessibility
at pro-memory genes. However, it remains unclear if TCF-1 expression in T cells responding to an infection
can create the epigenetic identity of memory T cells. The domains of TCF-1 required for targeting the
chromatin and its potential cooperating factors also remain unknown. How TCF-1 dependent changes on the
epigenome relate to pro-memory genes needs to be defined. To answer these questions, we will interrogate
the effect of TCF-1 and its potential partners on the chromatin state and accessibility of CD8+ T cells in vitro.
Using the state-of-the-art tools, we will generate the map of TCF-1 dependent 3D genome organization and
define how changes on the epigenome relate to memory genes. We will further translate these findings in vivo
exploiting single-cell epigenomic, transcriptomic, and flow cytometry assays. The expected outcome of this
proposal is a detailed understanding of the fundamental interaction between TCF-1 and the chromatin in
peripheral T cells which can be exploited to devise combination therapies including epigenetic editing to
selectively alter T cell fate at will.
该建议的目的是研究转录因子TCF-1在确定表观遗传身份中的作用
记忆CD8+ T细胞的记忆。我们的自适应免疫系统已经发展出独特的能力来记住病原体
通过生成记忆T细胞,在重新感染时保护宿主。更好
了解记忆T细胞分化对于制定限制T细胞反应的策略至关重要
器官移植或增强慢性感染期间T细胞反应。虽然知道
记忆CD8+ T细胞功能所必需的转录因子TCF-1是该机制
蛋白质控制记忆T细胞命运尚不清楚。最近,我们发现了一种机制
TCF-1控制T细胞的发展与其前所未有的创建染色质的能力有关
幼稚T细胞的可及性景观。我们发现TCF-1在基因组区域有选择地富集
在开发的最早阶段可以访问,这是这些可访问性所必需的
监管要素。在单细胞水平上,TCF-1可以决定T细胞中染色质的坐标开口。
此外,异位TCF-1可以直接消除非T细胞中的反射性染色质标记,从而产生从头开始
开放染色质并诱导T细胞基因的表达。尽管我们最近的数据决定了新角色
在T细胞开发过程中TCF-1上的TCF-1,我们的发现也提出了另一个关键问题:什么
TCF-1在记忆T细胞的表观遗传身份中的作用是吗?我们假设合作中的TCF-1
使用转录因子伴侣定义了记忆T细胞的表观遗传景观。我们的新初步数据
进一步表明在体外T细胞激活后TCF-1表达会导致染色质可及性的增长
在亲梅里基因。但是,尚不清楚TCF-1在T细胞中是否对感染产生反应
可以创建记忆T细胞的表观遗传认同。针对目标所需的TCF-1域
染色质及其潜在的合作因素也尚不清楚。 TCF-1如何依赖于
需要定义与促记忆基因相关的表观基因组。要回答这些问题,我们将审问
TCF-1及其潜在伴侣对CD8+ T细胞在体外的可及性的影响。
使用最先进的工具,我们将生成依赖TCF-1的3D基因组组织的地图
定义表观基因组的变化与记忆基因相关。我们将在体内进一步翻译这些发现
利用单细胞表观基因组学,转录组和流式细胞仪测定法。预期的结果
提案是对TCF-1和染色质之间基本相互作用的详细理解
外围T细胞可以探索以设计组合疗法,包括表观遗传编辑
选择性地改变T细胞命运。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Remodeling the chromatin landscape in T lymphocytes by a division of labor among transcription factors.
- DOI:10.1111/imr.12942
- 发表时间:2021-03
- 期刊:
- 影响因子:8.7
- 作者:Vahedi G
- 通讯作者:Vahedi G
TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors.
- DOI:10.1038/s41590-022-01232-z
- 发表时间:2022-07
- 期刊:
- 影响因子:30.5
- 作者:Wang, Wenliang;Chandra, Aditi;Goldman, Naomi;Yoon, Sora;Ferrari, Emily K.;Nguyen, Son. C.;Joyce, Eric F.;Vahedi, Golnaz
- 通讯作者:Vahedi, Golnaz
Assessment of network module identification across complex diseases
- DOI:10.1038/s41592-019-0509-5
- 发表时间:2019-09-01
- 期刊:
- 影响因子:48
- 作者:Choobdar, Sarvenaz;Ahsen, Mehmet E.;Marbach, Daniel
- 通讯作者:Marbach, Daniel
A Cosine Similarity-Based Method to Infer Variability of Chromatin Accessibility at the Single-Cell Level.
- DOI:10.3389/fgene.2018.00319
- 发表时间:2018
- 期刊:
- 影响因子:3.7
- 作者:Cai S;Georgakilas GK;Johnson JL;Vahedi G
- 通讯作者:Vahedi G
Stripenn detects architectural stripes from chromatin conformation data using computer vision.
- DOI:10.1038/s41467-022-29258-9
- 发表时间:2022-03-24
- 期刊:
- 影响因子:16.6
- 作者:Yoon S;Chandra A;Vahedi G
- 通讯作者:Vahedi G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Golnaz Vahedi其他文献
Golnaz Vahedi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Golnaz Vahedi', 18)}}的其他基金
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
剖析 1 型糖尿病免疫细胞的转录组学和表观基因组特征
- 批准号:
10829819 - 财政年份:2020
- 资助金额:
$ 45.17万 - 项目类别:
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
剖析 1 型糖尿病免疫细胞的转录组学和表观基因组特征
- 批准号:
10262966 - 财政年份:2020
- 资助金额:
$ 45.17万 - 项目类别:
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
剖析 1 型糖尿病免疫细胞的转录组学和表观基因组特征
- 批准号:
10658838 - 财政年份:2020
- 资助金额:
$ 45.17万 - 项目类别:
Critical role of TCF-1 on the epigenetic identity of memory T cells
TCF-1 对记忆 T 细胞表观遗传特性的关键作用
- 批准号:
10087956 - 财政年份:2019
- 资助金额:
$ 45.17万 - 项目类别:
Critical role of TCF-1 on the epigenetic identity of memory T cells
TCF-1 对记忆 T 细胞表观遗传特性的关键作用
- 批准号:
10320935 - 财政年份:2019
- 资助金额:
$ 45.17万 - 项目类别:
Super-enhancer structure defines a signature of inflammatory bowel disease (IBD)
超级增强子结构定义了炎症性肠病(IBD)的特征
- 批准号:
8749475 - 财政年份:2015
- 资助金额:
$ 45.17万 - 项目类别:
相似海外基金
Role of meningeal lymphatic vasculature in neuroimmune communication development
脑膜淋巴管系统在神经免疫通讯发育中的作用
- 批准号:
10566682 - 财政年份:2023
- 资助金额:
$ 45.17万 - 项目类别:
Humanized anti-CXCL1 antibody for bladder cancer therapeutics
用于膀胱癌治疗的人源化抗 CXCL1 抗体
- 批准号:
10290237 - 财政年份:2021
- 资助金额:
$ 45.17万 - 项目类别:
Humanized anti-CXCL1 antibody for bladder cancer therapeutics
用于膀胱癌治疗的人源化抗 CXCL1 抗体
- 批准号:
10454422 - 财政年份:2021
- 资助金额:
$ 45.17万 - 项目类别:
Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function
通过视网膜功能的体内细胞成像加速光感受器替代疗法
- 批准号:
10329081 - 财政年份:2021
- 资助金额:
$ 45.17万 - 项目类别:
Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity
开发 3D 肺泡组织模型、CRISPR 编辑和微生物免疫反应测定平台,以破译人类肺免疫
- 批准号:
10370727 - 财政年份:2020
- 资助金额:
$ 45.17万 - 项目类别: